Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.

MLA

Ida Kappel Buhl, et al. “Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.” PLoS ONE, vol. 11, no. 5, Jan. 2016, p. e0155123. EBSCOhost, https://doi.org/10.1371/journal.pone.0155123.

APA

Ida Kappel Buhl, Sarah Gerster, Mauro Delorenzi, Thomas Jensen, Peter Buhl Jensen, Fred Bosman, Sabine Tejpar, Arnaud Roth, Nils Brunner, Anker Hansen, & Steen Knudsen. (2016). Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data. PLoS ONE, 11(5), e0155123. https://doi.org/10.1371/journal.pone.0155123

Chicago

Ida Kappel Buhl, Sarah Gerster, Mauro Delorenzi, Thomas Jensen, Peter Buhl Jensen, Fred Bosman, Sabine Tejpar, et al. 2016. “Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.” PLoS ONE 11 (5): e0155123. doi:10.1371/journal.pone.0155123.